Texas Liver Institute & UT Health San Antonio Present
5th Annual GI and Liver Disease Conference for Primary Care and Nursing
Saturday, March 23, 2019
La Cantera Hill Country
16641 La Cantera Parkway
San Antonio, Texas 78256
7:30 AM – 4:30 PM
|7:30-8:15 AM||Buffet breakfast/non-accredited product theater|
|8:15-8:25 AM||Welcome (Dr. Eric Lawitz-Conference Chair)|
|Liver Session (Moderator: Dr. Naim Alkhouri)|
|8:25-8:50 AM||Hepatitis C elimination: Screening, linkage and cure (Dr. Eric Lawitz)|
|8:50-9:15 AM||Hepatitis B: Which treatments are currently available and what is on the horizon? (Dr. Fabian Rodas)|
|9:15-9:40 AM||Non-alcoholic fatty liver disease: Screening, current management and treatments on the horizon (Dr. Naim Alkhouri)|
|9:40-10:05 AM||Q&A/panel discussion|
|10:20-10:45 AM||Primary biliary cholangitis (PBC): Screening and treatment (Dr. Naim Alkhouri)|
|10:45-11:10 AM||Management of complications of cirrhosis: Hepatic encephalopathy and thrombocytopenia (Dr. Fred Poordad)|
|11:10-11:35 AM||Hepatocellular carcinoma: Screening, diagnosis and management (Dr. Nicole Loo)|
|11:35-11:55 AM||Q&A/panel discussion|
|11:55 AM-12:00 PM||Break/retrieve lunch|
|12:00-12:30 PM||Lunch/non-accredited product theater|
|12:30-1:00 PM||Lunch/non-accredited product theater|
|GI Session (Moderator: Dr. Sandeep Patel)|
|1:00-1:25 PM||Inflammatory bowel disease (IBD): Current treatment updates and more (Dr. Amy Schindler)|
|1:25-1:50 PM||Diagnosis and management of irritable bowel syndrome (IBS) (Dr. Elizabeth Coss)|
|1:50-2:15 PM||Management of chronic constipation (Dr. Juan Echavarria)|
|2:15-2:30 PM||Q&A/panel discussion|
|2:45-3:10 PM||Hepatobiliary neoplasms as they come into your office (Dr. Laura Rosenkranz)|
|3:10-3:35 PM||Colorectal cancer screening: Diagnosis and management (Dr. Glenn Gross)|
|3:35-4:00 PM||Pancreatic cancer: What can we do? (Dr. Sandeep Patel)|
|4:00-4:20 PM||Q&A/Panel discussion|
|4:20-4:30 PM||Meeting wrap-up/closing remarks|
Physicians (MD or DO):
Other healthcare professionals
(NP, PA, RN, PharmD, others):
Students (limited registrations):
* A limited number of free registrations will be given to full time students. In order to be considered, students must email email@example.com and provide the university, name of program, degree being pursued and expected graduation year.
For further information, please contact firstname.lastname@example.org
Credits Offered: AMA PRA Category 1 Credits™ – 7.25; Certificate of Attendance – 7.25
Learning Outcome: Understand current, evidence-based screening, treatment and care recommendations for patients with liver and gastrointestinal disease and incorporate this knowledge into practice.
- Apply screening, diagnosis and patient management strategies for chronic liver and gastrointestinal diseases including viral hepatitis, fatty liver disease, complications of cirrhosis, inflammatory bowel disease, irritable bowel syndrome, hepatocellular carcinoma, colon cancer and pancreatic cancer.
- Describe recent clinical advances, including future therapies for viral hepatitis, fatty liver disease, complications of cirrhosis, inflammatory bowel disease, irritable bowel syndrome and hepatocellular carcinoma.
Target Audience: MDs,PAs, APRNs, RNs and other allied health professionals/primary care providers with an interest in liver and gastrointestinal disease.
Accreditation: The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine designates this live activity up to a maximum of 7.25 AMA PRA Category 1 Credits™. Attendees can request a Certificate of Attendance claiming up to 7.25 hours for submission to their respective accrediting body.
Jointly Provided By: The Joe R. & Teresa Lozano Long School of Medicine and Texas Liver Institute.